(Q36799139)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453140%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

review article

1 reference

title

Low-grade albuminuria and cardiovascular risk : what is the evidence? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453140%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453140%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1

Roland E Schmieder

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453140%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Joachim Schrader

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453140%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Walter Zidek

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453140%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Ulrich Tebbe

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453140%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

W Dieter Paar

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453140%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

D Pittrow

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453140%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Michael Böhm

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453140%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

language of work or name

1 reference

26 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453140%20AND%20SRC:MED&resulttype=core&format=json

Clinical Research in Cardiology

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453140%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453140%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453140%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

247-257

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453140%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00392-007-0510-3

29 December 2019

exact match

0 references

cites work

Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00392-007-0510-3

Management of hypertension in patients with type 2 diabetes mellitus: guidelines based on current evidence

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00392-007-0510-3

Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00392-007-0510-3

Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria

21 January 2018

1 reference

12 December 2020

Albuminuria reflects widespread vascular damage. The Steno hypothesis.

1 reference

12 December 2020

Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

1 reference

12 December 2020

Is it time to measure microalbuminuria in hypertension?

1 reference

12 December 2020

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

12 December 2020

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

12 December 2020

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

12 December 2020

Angiotensin receptor blockers: powerful evidence with cardiovascular outcomes?

1 reference

12 December 2020

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

1 reference

12 December 2020

Microalbuminuria and all-cause mortality in treated hypertensive individuals: does sex matter? The Nord-Trøndelag Health Study (HUNT), Norway

1 reference

12 December 2020

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

1 reference

12 December 2020

Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity

1 reference

12 December 2020

Microalbuminuria modifies the mortality risk associated with electrocardiographic ST-T segment changes

1 reference

12 December 2020

Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects

1 reference

12 December 2020

The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature

1 reference

12 December 2020

Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective

1 reference

12 December 2020

Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group

1 reference

12 December 2020

Microalbuminuria as an early marker for cardiovascular disease

1 reference

12 December 2020

Urinary albumin excretion--a predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive men

1 reference

12 December 2020

A prospective study of microalbuminuria and incident coronary heart disease and its prognostic significance in a British population: the EPIC-Norfolk study

1 reference

12 December 2020

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes

1 reference

12 December 2020

Preventing microalbuminuria in type 2 diabetes

1 reference

12 December 2020

Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study

1 reference

12 December 2020

Low-Grade Albuminuria and the Risks of Hypertension and Blood Pressure Progression

1 reference

12 December 2020

Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.

1 reference

12 December 2020

Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects

1 reference

12 December 2020

Albuminuria and Poor Glycemic Control Predict Mortality in NIDDM

1 reference

12 December 2020

Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population

1 reference

12 December 2020

Prognostic significance of renal function in elderly patients with isolated systolic hypertension: results from the Syst-Eur trial

1 reference

12 December 2020

Urinary albumin excretion. An independent predictor of ischemic heart disease

1 reference

12 December 2020

Proteinuria is a risk factor for mortality over 10 years of follow-up. MRFIT Research Group. Multiple Risk Factor Intervention Trial

1 reference

12 December 2020

Proteinuria and mortality in diabetes: the WHO Multinational Study of Vascular Disease in Diabetes

1 reference

12 December 2020

Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study).

1 reference

12 December 2020

Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: a 4.4-year follow-up study. The Nord-Trøndelag Health Study (HUNT), Norway

1 reference

12 December 2020

Optimal dose of losartan for renoprotection in diabetic nephropathy

1 reference

12 December 2020

Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study

1 reference

12 December 2020

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

12 December 2020

The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus

1 reference

12 December 2020

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

1 reference

12 December 2020

Renal and systemic transvascular albumin leakage in severe atherosclerosis

1 reference

12 December 2020

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

12 December 2020

Systemic blood pressure and glomerular leakage with particular reference to diabetes and hypertension

1 reference

12 December 2020

Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy

1 reference

12 December 2020

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

12 December 2020

Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study)*.

1 reference

12 December 2020

Microalbuminuria during acute myocardial infarction; a strong predictor for 1-year mortality

1 reference

12 December 2020

Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria

1 reference

12 December 2020

Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death

1 reference

12 December 2020

Optimal antiproteinuric dose of losartan in nondiabetic patients with nephrotic range proteinuria

1 reference

12 December 2020

Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study

1 reference

12 December 2020

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

12 December 2020

Albuminuria: moving beyond traditional microalbuminuria cut-points

1 reference

12 December 2020

10.1007/S00392-007-0510-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17453140%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference